About this trial
The study aims to compare the effects of inspiratory muscle training and Baduanjin exercises on pulmonary function, exercise capacity, and quality of life in patients with hypertrophic cardiomyopathy. By investigating these interventions, the investigators seek to introduce novel approaches that can enhance pulmonary function, exercise capacity, and overall quality of life for these patients.
In the study, which will involve three groups-the control group, the inspiratory muscle training (IMT) group, and the Baduanjin group-it was calculated that a total of 51 patients, with 17 in each group (n = 17), should be included.
The IMT group will use an inspiratory muscle training device twice a day, every day of the week, for 15 minutes. This training will continue for 8 weeks, with supervision once a week and unsupervised sessions on the other days.
The Baduanjin group will participate in a 50-minute exercise program, which includes a 10-minute warm-up, a 30-minute routine of eight separate movements, and a 10-minute cool-down. This will occur three times a week (twice in person and once online) for 8 weeks.
Eligibility criteria
Qualifiers
Myocardial thickness in any region of the left ventricle is 15 mm or more on echocardiography or cardiac MRI
Clinically and hemodynamically stable (patients with NYHA Class I and II)
Patients over 18 years of age
Patients who provide informed consent
Disqualifiers
Acute decompensated heart failure
Decreased ejection fraction (<40%)
Unstable angina pectoris
Significant coronary artery disease (CAD)
Trial design
Treatments tested in this trial
- Inspiratory Muscle Training
- Baduanjin Exercise